Verge Genomics to Incorporate Emerald Digital Health Technology into its ALS Phase 1b Proof-of-Concept Clinical Trial Press ReleaseRob MaguireMay 23, 2023
Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 Press ReleaseRob MaguireJanuary 4, 2023
Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officer Press ReleaseRob MaguireDecember 6, 2022
Alice Zhang to present at Emergent BioSolutions "Horizon Talks" Series EventsRob MaguireNovember 29, 2022
CEO Alice Zhang to present at the 5th Annual Evercore ISI HealthCONx Conference 2022 EventsRob MaguireNovember 21, 2022
CEO Alice Zhang to present at the Piper Sandler 34th Annual Healthcare Conference EventsRob MaguireNovember 21, 2022
VERGE GENOMICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN NOVEMBER Press ReleaseRob MaguireNovember 21, 2022
Alice Zhang, CEO & Co-founder of Verge Genomics, Recognized Today by Both Fortune and Fierce Biotech as a Pioneer in AI-Driven Drug Discovery Press ReleaseRob MaguireNovember 14, 2022
Verge Genomics Initiates First-In-Human Dosing in Phase 1 Trial of VRG50635, A Novel Therapeutic for Amyotrophic Lateral Sclerosis Press ReleaseRob MaguireOctober 31, 2022
